Poniard Pharmaceuticals Inc. (PARD) 1.57 -0.04

Trade PARD
NOW!
Last Trade:1.56Short Ratio:5.30
Last Trade Time:4:00pmDay Range:1.56 - 1.62
Ask:1.57Year Range:1.50 - 9.14
Bid:1.56One Year Target:1.88
Open:1.61Exchange:NGM
Volume:1532268EBITDA:-38.9M
Prev. Close:1.60Market Cap:57.6M
50 Day Moving:1.6197Div Yield:
200 day moving:4.0349PE:

Related RealMoney articles from TheStreet.com

Cell Therapeutics, Zoom Technologies: Midday Volume Plays
Medivation: Biotech Stock Mailbag
Bonus Biotech Stock Mailbag: Medivation

U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter

Posted on 03/18/10 at 1:33pm
U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter PR Newswire SOUTH SAN FRANCISCO, Calif., March 18
Click here to read the rest of the article

SmarTrend Detects Continued Selling Pressure in Shares of Poniard Pharmaceuticals (PARD)

Posted on 03/15/10 at 12:24pm
SmarTrend identified a Downtrend for Poniard Pharmaceuticals (NASDAQ: PARD) on January 29, 2010 at $1.65. In approximately 1 month, Poniard Pharmaceuticals has returned 7.3% as of today's recent price of $1.53.
Click here to read the rest of the article

Poniard Pharmaceuticals Announces $6.3 Million Financing

Posted on 03/15/10 at 10:57am
Poniard Pharmaceuticals Announces $6.3 Million Financing PR Newswire SOUTH SAN FRANCISCO, Calif., March 15
Click here to read the rest of the article

Poniard Pharmaceuticals, Inc., (Public, NASDAQ:PARD) Abstracts for new drug candidate presented in Cancer and Biology Therapy

Posted on 03/12/10 at 4:00am
(EMAILWIRE.COM, March 12, 2010 ) NY, NY TapeBeat.Com, the news and research portal for the serious investor is proud to present information regarding Poniard Pharmaceuticals, Inc., (Public, NASDAQ:PARD). Poniard Pharmaceuticals, Inc.
Click here to read the rest of the article

Monday`s Most Active Losers (PALM, ICO, GMO, INTC, Alcoa, GE, PARD, SSP)

Posted on 03/09/10 at 4:00am
(EMAILWIRE.COM, March 09, 2010 ) Dallas, Tx - Palm, Inc. (NASDAQ:PALM) lost 2.80% to $5.55 on 32.07 million shares after the company was downgraded from an analyst at Macquarie this morning to Underperform. Macquarie's new price target on Palm suggests further downside of more than 30% from where the stock is trading this morning.
Click here to read the rest of the article

SmarTrend's Trend Spotter See Continued Downward Momentum on Shares of Poniard Pharmaceuticals (PARD)

Posted on 03/08/10 at 12:27pm
SmarTrend identified a Downtrend for Poniard Pharmaceuticals (NASDAQ: PARD) on January 29, 2010 at $1.65. In approximately 1 month, Poniard Pharmaceuticals has returned 3% as of today's recent price of $1.60.
Click here to read the rest of the article

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results

Posted on 03/08/10 at 9:18am
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results - Conference Call Today at 8:30 a.m. Eastern Time - PR Newswire SOUTH SAN FRANCISCO, Calif., March 8
Click here to read the rest of the article

Monday`s Most Active Stock Losers (PALM, YRCW, INTC, Alcoa, GE, PARD, SSP)

Posted on 03/08/10 at 4:00am
(EMAILWIRE.COM, March 08, 2010 ) Dallas, Tx - Palm, Inc. (NASDAQ:PALM) falls 3.68% to $5.50 on 3.44 million shares after the company was downgraded from an analyst at Macquarie this morning to Underperform. Macquarie's new price target on Palm suggests further downside of more than 30% from where the stock is trading this morning.
Click here to read the rest of the article

Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium

Posted on 03/05/10 at 3:48pm
Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium PR Newswire SOUTH SAN FRANCISCO, Calif., March 5
Click here to read the rest of the article

Notable Healthcare Stocks (SOMX, PARD, CRXX, ANPI, CBRX)

Posted on 03/05/10 at 4:00am
(EMAILWIRE.COM, March 05, 2010 ) Dallas, Tx - Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) added 11.33% to $4.03 on 4.48 million shares. The stock price is up over 75% in the last six months of trading sessions.
Click here to read the rest of the article